A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia
Clinical trial NCT06898255 · RECRUITING
Trial details
- NCT number
- NCT06898255
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-24
- Primary completion
- 2026-06-08
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.